INS and Hypoglycemia: The odds of hypoglycemia associated with SBB vs. carvedilol was not significantly different in basal insulin non-users (OR 1.90, 95% CI 0.90–4.02, p = 0.09) or users (OR 0.50, 95% CI 0.22–1.14, p = 0.10).